Epilepsy

Ukrainian health officials have released the list of conditions that will qualify patients for the country’s new medical cannabis program.

Lawmakers in Japan’s House of Representatives have passed a bill to legalize cannabis-derived pharmaceuticals. The bill would also establish legal restrictions on general cannabis use, which was not previously referenced under federal law.

The Kentucky Senate will not vote on the state’s House-approved medical cannabis legislation because, according to Senate Majority Leader Damon Thayer (R), there are “not enough votes” to pass the bill.

Kentucky’s GOP-controlled House of Representatives voted 59-64 to pass a bill giving patients with certain severe illnesses access to a state medical cannabis program.

The Kentucky House Judiciary Committee passed a medical cannabis bill sponsored and supported by the state’s Republican lawmakers.

A recent study found that the incidence of epileptic seizures in children decreased an average of 86% when treated with whole-plant cannabis.

Green Active, a UK-based CBD company, announced a donation program to help the family of an eight-year-old cannabis patient pay for his medicine as the NHS refuses to write a prescription providing it to the family for free.

Billy Caldwell, who became the figurehead of medical cannabis policy changes in the UK, will receive his first bottle of cannabis-derived medicine two years after the necessary reforms took place.

The FDA has expanded the label of Epidiolex, the first CBD-based medication approved by the federal agency, to treat seizures resulting from tuberous sclerosis complex.

The DEA has removed Epidiolex, the CBD-based epilepsy medication made by GW Pharmaceuticals, from the federal controlled substances list.

The European Union has approved Epidiolex for the treatment of two childhood epilepsy conditions. It’s the first time the EU has approved a cannabis-based medication.

The UK’s National Institute for Health Care and Excellence has decided against recommending CBD products with clobazam for treating treatment-resistant epilepsy conditions, citing CBD’s “unknown” long-term efficacy.

Washington state has officially passed two laws meant to improve the state’s medical cannabis program; one bill allows student patients to be administered cannabis products at school and the other allows patients to renew their annual qualification online.